Rapid prescreening of Papanicolaou smears: A practical and efficient quality control strategy

Cancer

Volumn 108, Issue 1, 2006, Pages 21-26

  Djemli, Amina ^a   Khetani, Karim ^a   Auger, Manon ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Gynecologic cytology; Prescreening; Quality control; Rapid screening; Rescreening

Indexed keywords

ARTICLE; CYTOPATHOLOGY; ENDOMETRIUM CYTOLOGY; FALSE NEGATIVE RESULT; FEMALE; GYNECOLOGIC CANCER; GYNECOLOGIC INFECTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUALITY CONTROL; RAPID PRESCREENING; RELIABILITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL;

FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MASS SCREENING; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33344466356     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21424     Document Type: Article

References (34)

1. Renshaw AA. Measuring sensitivity in gynecological cytology: a review. Cancer (Cancer Cytopathol). 2002;96:210-217.
2. Clinical Laboratory Improvement amendments of 1988 (public law 100578). Fed Reg. 1990;55:9538-9574.
3. United States Department of Health and Human Services, Health Care Financing Administration: Medicare, Medicaid and CLIA programs. Amended 1988. Fed Reg. 1992;57:493-1257.
4. Canadian Society of Cytopathology. Guidelines for practice and quality assurance in Cytopathology, 2005. Available from URL: http://cap.medical.org/ cytology [accessed October 25, 2005].
5. Melamed MR. Presidential address. Acta Cytol. 1973;17:285-288.
6. Melamed MR, Flehinger BJ. Reevaluation of quality assurance in the cytology laboratory. Acta Cytol. 1992;36:461-465.
7. Jordon SW. Great expectations: cytology provisions of CLIA'88 and the role of professional societies. In: Jordan SW, editor. Cytopathology annual. Baltimore: Williams and Wilkins, 1992:235-247.
8. Halford JA, Wright RG, Ditchmen EJ. Quality assurance in cervical cytology screening. Comparison of rapid rescreening and the PAPNET testing system. Acta Cytol. 1997;41:79-81.
9. Rosenthal DL, Acosta D, Peters RK. Computer-assisted rescreening of clinically important false cervical smears using the PAPNET testing system. Acta Cytol. 1996;40:120-126.
10. Rowe LR, Marshall CJ, Bentz JS. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology. Cancer (Cancer Cytopathol). 2002;96:325-329.
11. Halford JA, Wright RG, Ditchmen EJ. Prospective study of PAPNET: review of 25656 pap smears negative on manual screening and rapid rescreening. Cytopathology. 1999;10:317-323.
12. Wilson NJ, Molyneux AJ. Rapid review in cervical cytology: a retrospective review of cases detected on rapid review within a DGH cytology department and subsequent outcome. Cytopathology. 2004;15:93-96.
13. Faraker CA. Partial rescreening of all negative smears: an improved method of quality assurance in laboratories undertaking cervical screening. Cytopathology. 1993;4:47-50.
14. Lemay C, Meisels A. 100% Rapid (partial) rescreening for quality assurance. Acta Cytol. 1999;43:86-88.
15. Johnson SJ, Hair T, Gibson L, Ridley B, Wadehra V. An assessment of partial rescreening as an internal quality control method for cervical smears. Cytopathology. 1995;6:376-387.
16. Faraker CA. Rapid review. Cytopathology. 1998;9:71-76.
17. Baker A, Melcher D, Smith R. Role of re-screening of cervical smears in internal quality control. J Clin Pathol. 1995;48:1002-1004.
18. Dudding N, Hewer EM, Lancucki L, Rice S. Rapid screening: a comparative study. Cytopathology. 2001;12:235-248.
19. Arbyn M, Schenck U. Detection of false negative Pap smears by rapid reviewing a metaanalysis. Acta Cytol. 2000;44:949-957.
20. Diehl ARS, Prolla JC. Rapid rescreening of cervical smears for internal quality control. Acta Cytol. 1998;42:949-953.
21. National Health Service Cervical Screening Programme. Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytology, 2nd ed. Pub. No. 1. Sheffield, UK: National Health Service Cervical Screening Programme, 2000.
22. Shield PW, Cox C. The sensitivity of rapid (partial review) of cervical smears. Cytopathology. 1998;9:84-92.
23. Renshaw AA, Cronin JA, Minter LJ, et al. Performance characteristics of rapid (30 seconds) prescreening. Implications for calculating the false-negative rate and comparison with other quality assurance techniques. Am J Clin Pathol. 1999;111:517-522.
24. Brooke D, Dudding N, Sutton J. Rapid (partial) prescreening of cervical smears: the quality control method of choice? Cytopathology. 2002;13:191-199.
25. Smith J, Nicholas D, Boyd K, Deacon-Smith R. Rapid prescreening: a validated quality assurance measure in cervical cytology. Cytopathology. 2003;14:275-280.
26. Faraker CA, Boxer ME. Rapid review (partial rescreening) of cervical cytology. Four years experience and quality assurance implications. J Clin Pathol. 1996;49:587-591.
27. Solomon D, Nayar R. The Bethesda System for reporting cervical cytology. Definitions, criteria, and explanatory notes, 2nd ed. New York: Springer, 2004.
28. Renshaw AA. Analysis of error in calculating the false-negative rate in the interpretation of cervicovaginal smears. The need to review abnormal cases. Cancer (Cancer Cytopathol). 1997;81:264-271.
29. Renshaw AA. A practical problem with calculating the false-negative rate of Papanicolaou smear interpretation by rescreening negative cases alone. Cancer (Cancer Cytopathol). 1999;87:351-353.
30. Renshaw AA, Lezon KM, Wilbur DC. The human false-negative rate of rescreening Pap tests: measured in a two arm prospective clinical trial. Cancer (Cancer Cytopathol). 2001;93:106-110.
31. Renshaw AA, Bellerose B, DiNisio SA, Minter LJ, Lee KR. False negative rate of cervical cytologic smear screening as determined by rapid rescreening. Acta Cytol. 1999;43:344-350.
32. Baker A, Melcher DH. Rapid cervical cytology screening. Cytopathology. 1991;2:299-301.
33. Arbyn M, Schenck U, Ellison E, Hanselaar A. Metaanalysis of the accuracy of rapid prescreening relative to full screening of Pap smears. Cancer (Cancer Cytopathol). 2003;99:9-16.
34. Farell DJ, Bilkhu S, Gibson LM, Cummings L, Wadehra V. Rapid screening of cervical smears as a method of internal quality control. For how long should we rescreen? Acta Cytol. 1997;41:251-260.